完全胸骨保留双侧开胸HeartMate 3植入连续10例病例系列
该病例系列描述了采用双侧开胸行完全胸骨保留(CSS)HeartMate 3左心室辅助装置(LVAD)植入的技术,并报告了连续10例患者的早期临床结局。中位ICU住院日为3.5天,无患者因术后出血再探查,无右心衰竭、卒中、肾衰竭、肝衰竭或心肌梗死发生。中位住院日为14.5天(四分位距12至17天)。作者认为CSS入路可能减少右心衰竭、出血、插管时间和ICU住院日,但需进一步研究明确其相对于正中胸骨切开术的优势。
要点
- CSS HeartMate 3植入采用双侧开胸,连续10例患者早期无出血再探查。
- 术后无右心衰竭、卒中、肾衰竭、肝衰竭或心肌梗死发生。
- 中位ICU住院日3.5天,中位住院日14.5天(四分位距12至17天)。
核心结论
- CSS入路行HeartMate 3 LVAD植入的早期结局提示可能减少右心衰竭、出血、插管时间和ICU住院日。
- 需进一步研究以充分阐明CSS LVAD植入相较于正中胸骨切开术的优势。
研究设计与样本
- 单中心病例系列,描述完全胸骨保留(CSS)HeartMate 3 LVAD植入技术并报告连续10例患者的早期临床结局。
- 技术采用双侧开胸完成LVAD植入。
主要发现
- 中位ICU住院日为3.5天。
- 无患者因术后出血需再探查。
- 无右心衰竭、卒中、肾衰竭、肝衰竭或心肌梗死发生。
- LVAD植入后中位住院日为14.5天(四分位距12至17天)。
临床怎么用
- 对于选定晚期心力衰竭患者,可考虑采用双侧开胸的完全胸骨保留技术植入HeartMate 3 LVAD。
- 该技术可能有助于减少术后出血、右心衰竭和ICU住院时间,但需进一步研究确认。
局限性
- 样本量小(连续10例),为单中心病例系列。
- 缺乏与正中胸骨切开术的对照比较。
- 早期结局需进一步研究充分阐明CSS入路的优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Left ventricular assist device (LVAD) therapy has been the standard of care for selected patients with advance heart failure. Even though considerable strides have been achieved with the introduction of the newest centrifugal pump, therapy is still burdened with significant perioperative complications. Smaller devices, along with improved techniques and instruments, have encouraged the adoption of minimally invasive cardiac surgery (MICS) techniques for LVAD implantation to improve perioperative outcomes. METHODS: We describe a technique for complete sternal-sparing (CSS) HeartMate 3 (Abbott Laboratories, Abbott Park, IL) left ventricular assist device (LVAD) implantation using bilateral thoracotomies and discuss early clinical outcomes of the first ten consecutive patients who underwent CSS implantation of the HeartMate 3 LVAD at our institution. RESULTS: The median length of stay in the intensive care unit was 3.5 days. No patients required reexploration for postoperative bleeding. There was no incidence of right ventricle failure, stroke, renal failure, hepatic failure, or myocardial infarction. The median length of hospitalization after LVAD implantation was 14.5 days (interquartile range, 12 to 17 days). CONCLUSIONS: Our early outcomes suggest that the CSS approach may reduce the incidence of right ventricular failure, bleeding, intubation time, and intensive care unit length of stay. Further studies are needed to fully elucidate the advantages of CSS LVAD implantation compared with median sternotomy.
引用
- Wood KL, Ayers BC, Sagebin F, et al. Complete Sternal-Sparing HeartMate 3 Implantation: A Case Series of 10 Consecutive Patients. Ann Thorac Surg. 2018. PMID: 30444989. doi:10.1016/j.athoracsur.2018.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。